FR2797398B1 - MICROPARTICLES FOR PULMONARY ADMINISTRATION - Google Patents

MICROPARTICLES FOR PULMONARY ADMINISTRATION

Info

Publication number
FR2797398B1
FR2797398B1 FR9910411A FR9910411A FR2797398B1 FR 2797398 B1 FR2797398 B1 FR 2797398B1 FR 9910411 A FR9910411 A FR 9910411A FR 9910411 A FR9910411 A FR 9910411A FR 2797398 B1 FR2797398 B1 FR 2797398B1
Authority
FR
France
Prior art keywords
microparticles
pulmonary administration
pulmonary
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9910411A
Other languages
French (fr)
Other versions
FR2797398A1 (en
Inventor
Joel Richard
Claire Dulieu
Meurlay Dominique Le
Jean Pierre Benoit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mainelab SA
Original Assignee
Mainelab SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9910411A priority Critical patent/FR2797398B1/en
Application filed by Mainelab SA filed Critical Mainelab SA
Priority to PCT/FR2000/002282 priority patent/WO2001012160A1/en
Priority to AU70104/00A priority patent/AU784168B2/en
Priority to IL14806300A priority patent/IL148063A0/en
Priority to HU0202545A priority patent/HUP0202545A3/en
Priority to MXPA02001520A priority patent/MXPA02001520A/en
Priority to EP00958655A priority patent/EP1204409A1/en
Priority to KR1020027001717A priority patent/KR20020038719A/en
Priority to CA002380883A priority patent/CA2380883A1/en
Priority to CNB008116660A priority patent/CN1220484C/en
Priority to JP2001516507A priority patent/JP2003506479A/en
Publication of FR2797398A1 publication Critical patent/FR2797398A1/en
Priority to NO20020555A priority patent/NO20020555L/en
Priority to ZA200201109A priority patent/ZA200201109B/en
Application granted granted Critical
Publication of FR2797398B1 publication Critical patent/FR2797398B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/22—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
FR9910411A 1999-08-11 1999-08-11 MICROPARTICLES FOR PULMONARY ADMINISTRATION Expired - Lifetime FR2797398B1 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR9910411A FR2797398B1 (en) 1999-08-11 1999-08-11 MICROPARTICLES FOR PULMONARY ADMINISTRATION
JP2001516507A JP2003506479A (en) 1999-08-11 2000-08-09 Fine particles for pulmonary administration
IL14806300A IL148063A0 (en) 1999-08-11 2000-08-09 Microparticles for pulmonary administration
HU0202545A HUP0202545A3 (en) 1999-08-11 2000-08-09 Microparticles for pulmonary administration
MXPA02001520A MXPA02001520A (en) 1999-08-11 2000-08-09 Microparticles for pulmonary administration.
EP00958655A EP1204409A1 (en) 1999-08-11 2000-08-09 Microparticles for pulmonary administration
PCT/FR2000/002282 WO2001012160A1 (en) 1999-08-11 2000-08-09 Microparticles for pulmonary administration
CA002380883A CA2380883A1 (en) 1999-08-11 2000-08-09 Microparticles for pulmonary administration
CNB008116660A CN1220484C (en) 1999-08-11 2000-08-09 Microparticles for pulmonary administation
AU70104/00A AU784168B2 (en) 1999-08-11 2000-08-09 Microparticles for pulmonary administration
KR1020027001717A KR20020038719A (en) 1999-08-11 2000-08-09 Microparticles for pulmonary administration
NO20020555A NO20020555L (en) 1999-08-11 2002-02-04 Microparticles for lung administration
ZA200201109A ZA200201109B (en) 1999-08-11 2002-02-08 Microparticles for pulmonary administration.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9910411A FR2797398B1 (en) 1999-08-11 1999-08-11 MICROPARTICLES FOR PULMONARY ADMINISTRATION

Publications (2)

Publication Number Publication Date
FR2797398A1 FR2797398A1 (en) 2001-02-16
FR2797398B1 true FR2797398B1 (en) 2002-10-18

Family

ID=9549086

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9910411A Expired - Lifetime FR2797398B1 (en) 1999-08-11 1999-08-11 MICROPARTICLES FOR PULMONARY ADMINISTRATION

Country Status (13)

Country Link
EP (1) EP1204409A1 (en)
JP (1) JP2003506479A (en)
KR (1) KR20020038719A (en)
CN (1) CN1220484C (en)
AU (1) AU784168B2 (en)
CA (1) CA2380883A1 (en)
FR (1) FR2797398B1 (en)
HU (1) HUP0202545A3 (en)
IL (1) IL148063A0 (en)
MX (1) MXPA02001520A (en)
NO (1) NO20020555L (en)
WO (1) WO2001012160A1 (en)
ZA (1) ZA200201109B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809309B1 (en) * 2000-05-23 2004-06-11 Mainelab EXTENDED RELEASE MICROSPHERES FOR INJECTION DELIVERY
CN1642533A (en) * 2002-03-18 2005-07-20 山之内制药株式会社 Powdery medicinal compositions for inhalation and process for producing the same
JP2005279334A (en) * 2004-03-26 2005-10-13 Kao Corp Production method for composite particle
EP1904219A4 (en) 2005-07-15 2011-07-27 Map Pharmaceuticals Inc Method of particle formation
EP1757361A1 (en) * 2005-08-23 2007-02-28 Feyecon Development & Implementation B.V. Process for the preparation of encapsulates through precipitation
US20100034888A1 (en) * 2006-09-15 2010-02-11 Hubert Clemens Pellikaan Granulate containing a pharmaceutically active substance and method for its manufacture
CN101143131B (en) * 2006-09-15 2012-03-07 国家纳米技术与工程研究院 Method for preparing human insulin inhaled dry powder using with supercritical fluid technology
AU2008232413B2 (en) * 2007-03-23 2013-09-19 VERO Biotech LLC. Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
KR101102834B1 (en) * 2010-02-24 2012-01-05 충남대학교산학협력단 New methods and apparatus for preparing liposomes
JP5672554B2 (en) * 2010-08-19 2015-02-18 Ｊｃｒファーマ株式会社 Composition for subcutaneous or transdermal absorption
CN102872027B (en) * 2012-09-18 2014-03-12 刘晓忠 Preparation of medicine granules for treating asthma and pneumonopathy and preparation of suction type compound aerosol of granules

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04222662A (en) * 1990-12-25 1992-08-12 Nippon Steel Chem Co Ltd Method for forming polymer film to surface of solid
EP0706821A1 (en) * 1994-10-06 1996-04-17 Centre De Microencapsulation Method of coating particles
DE69618938T2 (en) * 1995-03-28 2002-10-31 Fidia Advanced Biopolymers Srl NANOSPHERES WITH A BIO-COMPATIBLE POLYSACCHARIDE
FR2753639B1 (en) * 1996-09-25 1998-12-11 PROCESS FOR THE PREPARATION OF MICROCAPSULES OF ACTIVE MATERIALS COATED WITH A POLYMER AND NOVEL MICROCAPSULES OBTAINED IN PARTICULAR BY THE PROCESS
US5766637A (en) * 1996-10-08 1998-06-16 University Of Delaware Microencapsulation process using supercritical fluids
WO1998031346A1 (en) * 1997-01-16 1998-07-23 Massachusetts Institute Of Technology Preparation of particles for inhalation
JPH1147681A (en) * 1997-08-05 1999-02-23 Kira Keshohin Kk Method for coating fine particles by using supercritical fluid, and coated material
JPH11197494A (en) * 1998-01-13 1999-07-27 Kenji Mishima Microparticle coating using supercritical fluid

Also Published As

Publication number Publication date
ZA200201109B (en) 2002-10-30
KR20020038719A (en) 2002-05-23
CN1461211A (en) 2003-12-10
IL148063A0 (en) 2002-09-12
CN1220484C (en) 2005-09-28
MXPA02001520A (en) 2003-07-21
NO20020555D0 (en) 2002-02-04
AU784168B2 (en) 2006-02-16
EP1204409A1 (en) 2002-05-15
WO2001012160A1 (en) 2001-02-22
HUP0202545A2 (en) 2004-03-01
AU7010400A (en) 2001-03-13
JP2003506479A (en) 2003-02-18
CA2380883A1 (en) 2001-02-22
FR2797398A1 (en) 2001-02-16
NO20020555L (en) 2002-04-09
HUP0202545A3 (en) 2004-05-28

Similar Documents

Publication Publication Date Title
ATE392890T1 (en) HYDROGEL-CONTROLLED DOSAGE FORM
NO994094D0 (en) riser
NO20014286D0 (en) Three-phase
NO20015175D0 (en) Pharmaceutical composition
ATE232364T1 (en) CASTING COMPOSITION
NO20015149L (en) New pharmaceutical preparation
NO20022606D0 (en) Pharmaceutical combinations
NO20015510D0 (en) Medication for local application
DE50015811D1 (en) retarder
NO20014926D0 (en) Pharmaceutical compounds
NO20015148L (en) New pharmaceutical preparation
FR2797398B1 (en) MICROPARTICLES FOR PULMONARY ADMINISTRATION
DE50015381D1 (en) retarder
ID27403A (en) SCOOTER-FLOOR STRUCTURE
FI4488U1 (en) Pharmaceutical composition
NO20015104L (en) New pharmaceutical preparation
ATA19762000A (en) HOOK BRIDE
DE60029208D1 (en) continuous casting
NO20016430L (en) Pharmaceutical complex
DK1218127T3 (en) casting roll
NO20021036L (en) Pharmaceutical preparation
DE29906967U1 (en) formwork
DE50003442D1 (en) HANGER
DE29901077U1 (en) Hangers
DE60010173D1 (en) sizer

Legal Events

Date Code Title Description
TP Transmission of property
PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20